Profile photo Peter van Hasselt

Peter van Hasselt

Associate Professor - medical

Strategic program(s):

Biography

2020-present      Member of the board of the WKZ Research Fund

2020-2022          Manager Research of the Division 'Child' at the UMC Utrecht

2019-present      Associate Professor (Universitair hoofddocent UHD)

2017-present      Head of Department Metabolic diseases 

2017-present       'Opleider' at department of Metabolic Diseases

2017-2020          Head of Cluster C (portfolios Science, Finance, Operational Excellence, Capacity management) at WKZ  

2017-2022         Member of Leadership team Division 'Child', UMC Utrecht     

2016-2020           Member of the scientific committee of the WKZ Research Fund

2015-present       Head of Section Metabolic Diseases NVK

2012-2017           'Plaatsvervangend Opleider' Metabolic Diseases (WKZ)

2009-present       Staff member at department of Metabolic Diseases

2007-present       Pediatrician for Metabolic Diseases, Wilhelmina Children’s Hospital, Utrecht.

2007-2009           Temporary Staff Metabolic Diseases & PhD (WKZ)

2004-2007           Subspecialty training (fellowship) for Metabolic Diseases, Wilhelmina Children’s Hospital. Head: Dr. T.J. de Koning

1998-1999           Physician-researcher (Herseninstituut, Amsterdam)

1997-1998           Pediatrician non-trainee (WKZ, Neonatology)

1995                    Student-researcher (UMCG Pharmacology)

Recent publications

Imaging flow cytometry reveals divergent mitochondrial phenotypes in mitochondrial disease patients Irena J.J. Muffels, Richard Rodenburg, Hanneke L.D. Willemen, Désirée van Haaften-Visser, Hans Waterham, Niels Eijkelkamp, Sabine A. Fuchs, Peter M. van Hasselt
iScience, 2025, vol. 28
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II) Giancarlo Parenti, Simona Fecarotta, Marianna Alagia, Federica Attaianese, Alessandra Verde, Antonietta Tarallo, Vincenza Gragnaniello, Athanasia Ziagaki, Maria Jose’ Guimaraes, Patricio Aguiar, Andreas Hahn, Olga Azevedo, Maria Alice Donati, Beata Kiec-Wilk, Maurizio Scarpa, Nadine A.M.E. van der Beek, Mireja Del Toro Riera, Dominique P. Germain, Hidde Huidekoper, Johanna M.P. van den Hout, Ans T. van der Ploeg, Jiri Zeman, Peter Witters, Natalie Weinhold, Suresh Vijay, Peter M. van Hasselt, Kurt Ullrich, Ivailo Tournev, Alessandro Salviati, Frank Rutsch, Dominique Roland, Dariusz Rokicki, Esmeralda Rodrigues, György Pfliegler, Diana Miclea, Esmeralda Martins, Elena Martín-Hernández, Veroniki Komninaka, Sandra Kingma, Simon Jones, Tarekegn G. Hiwot, Julia Hennermann, Nathalie Guffon-Fouilhoux, Salvatore Grosso, Antonio González Meneses López, Serena Gasperini, Ana M. Gaspar, Ana Ferreira, Francois Eyskens, Dries Dobbelaere,
Orphanet Journal of Rare Diseases, 2024, vol. 19
Timing of cerebral damage in molybdenum cofactor deficiency Elise A. Ferreira, Floris C. Hofstede, Hanneke A. Haijes-Siepel, Klaske D. Lichtenbelt, Lou Pistorius, Monique G.M. de Sain-van der Velden, Peter G.J. Nikkels, Maarten H. Lequin, Linda S. de Vries, Saskia N. van der Crabben, Peter M. van Hasselt
Genetics in Medicine Open, 2024, vol. 2
High-dose ERT, rituximab, and early HSCT in an infant with Wolman’s disease Siawosh K. Eskandari, Elisabeth G.M. Revenich, Dirk J. Pot, Foekje de Boer, Marc Bierings, Francjan J. van Spronsen, Peter M. van Hasselt, Caroline A. Lindemans, Charlotte M.A. Lubout
New England Journal of Medicine, 2024, vol. 390, p.623-629
Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders Roland Posset, Sven F. Garbade, Florian Gleich, Svenja Scharre, Jürgen G. Okun, Andrea L. Gropman, Sandesh C.S. Nagamani, Ann Catrin Druck, Friederike Epp, Georg F. Hoffmann, Stefan Kölker, Matthias Zielonka, Nicholas Ah Mew, Jennifer Seminara, Lindsay C. Burrage, Gerard T. Berry, Margo Breilyn, Andreas Schulze, Cary O. Harding, Susan A. Berry, Derek Wong, Shawn E. McCandless, Matthias R. Baumgartner, Laura Konczal, Can Ficicioglu, George A. Diaz, Curtis R. Coughlin, Gregory M. Enns, Renata C. Gallagher, Christina Lam, Tamar Stricker, Greta Wilkening, Carlo Dionisi-Vici, Dries Dobbelaere, Javier Blasco-Alonso, Alberto B. Burlina, Peter Freisinger, Peter M. van Hasselt, Anastasia Skouma, Allan M. Lund, Roshni Vara, Adrijan Sarajlija, Andrew A. Morris, Anupam Chakrapani, Ivo Barić, Persephone Augoustides-Savvopoulou, Yin Hsiu Chien, Elisenda Cortès-Saladelafont, Francois Eyskens, Gwendolyn Gramer, ,
Genetics in Medicine, 2024, vol. 26
Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination Paula Ayuso-García, Alejandro Sánchez-Rueda, Sergio Velasco-Avilés, Miguel Tamayo-Caro, Aroa Ferrer-Pinós, Cecilia Huarte-Sebastian, Vanesa Alvarez, Cristina Riobello, Selene Jiménez-Vega, Izaskun Buendia, Jorge Cañas-Martin, Héctor Fernández-Susavila, Adrián Aparicio-Rey, Eva M. Esquinas-Román, Carlos Rodríguez Ponte, Romane Guhl, Nicolas Laville, Encarni Pérez-Andrés, José L. Lavín, Monika González-Lopez, Nuria Macías Cámara, Ana M. Aransay, Juan José Lozano, James D. Sutherland, Rosa Barrio, María Luz Martinez-Chantar, Mikel Azkargorta, Félix Elortza, Mario Soriano-Navarro, Carlos Matute, María Victoria Sánchez-Gómez, Laura Bayón-Cordero, Alberto Pérez-Samartín, Susana B. Bravo, Thimo Kurz, Tomas Lama-Díaz, Miguel G. Blanco, Saif Haddad, Christopher J. Record, Peter M. van Hasselt, Mary M. Reilly, Marta Varela-Rey, Ashwin Woodhoo
Science advances, 2024, vol. 10

External positions

bestuurslid - UMD is een samenwerking tussen de zes universitaire metabole centra en de patientenvereniging - UMD

advies - toekomstige medicatie metabole ziekten - ZIN (Zorg Instituut Nederland, previously VWS)